Generalized atrophic benign epidermolysis bullosa: Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency

Archives of Dermatology

Volumn 132, Issue 2, 1996, Pages 145-150

  Jonkman, Marcel F ^a   De Jong, Marcelus C J M ^a   Heeres, Klaas ^a   Steijlen, Peter M ^b   Owaribe, Katsushi ^d   Küster, Wolfgang ^e   Meurer, Michael ^f   Gedde Dahl Jr , Tobias ^h   Sonnenberg, Arnoud ^c   Bruckner Tuderman, Leena ^g  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d NAGOYA UNIVERSITY   (Japan)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; KALININ; MESSENGER RNA; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPIDERMOLYSIS BULLOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MALE; PEMPHIGOID; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEFICIENCY; SKIN BIOPSY; ULTRASTRUCTURE;

ADOLESCENT; ADULT; AGED; AUTOANTIGENS; CARRIER PROTEINS; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; COLLAGEN; CYTOSKELETAL PROTEINS; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPITOPES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; SKIN;

EID: 13344282732     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.132.2.145     Document Type: Article

References (32)

1. Hintner H, Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol. 1982, 118:375-384.
2. Schnyder UW, Anton-Lamprecht I. Zur Klinik der Epidermolysen mit junktionäler Blasenbildung Dermatologica. 1979;159:402-406.
3. Hashimoto I, Schnyder UW, Anton-Lamprecht I. Epidermolysis bullosa hereditaria with junctional blistering in an adult. Dermatologica. 1976;152:72-86.
4. Fine J-D, Bauer EA, Briggaman RA, et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. J Am Acad Dermatol. 1991;24:119-135.
5. Jonkman MF, De Jong MCJM, Heeres K, et al. 180-kd bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest. 1995;95.1345-1352.
6. Jonkman MF, De Jong MCJM, Heeres K, et al. 180-kd bullous pemphigoid antigen (BPAG2) is not expressed in generalized atrophic benign epidermolysis bullosa J Invest Dermatol. 1994,102 609. Abstract.
7. McGrath JA, Pulkkinen L, Christiano AM, Leigh IM, Eady RAJ, Uitto J. Altered laminin 5 expression due to mutations in the gene encoding the β3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol. 1995; 104:467-474
8. Giudice GJ, Emery DJ, Diaz LA. Cloning and primary structural analysis of the bullous pemhigoid autoantigen BP180 J Invest Dermatol. 1992;99:243-250.
9. Li K, Tamai K, Tan ML, Uitto J Cloning of type XVII collagen. J Biol Chem. 1993;268:8825-8834.
10. Peterseim U, Bruckner-Tuderman L, Jonkman MF, Meuer M. Generalized atrophic benign form of junctional epidermolysis bullosa. Br J Dermatol. In press.
11. Gedde-Dahl T Jr, Anton-Lamprecht I. Epidermolysis bullosa. In: Emory AEH, Rimoin DL, eds. Principles and Practice of Medical Genetics. New York, NY Churchill-Livingstone Inc; 1983:672-687.
12. Zortea-Caflisch C. Epidermolysis bullosa atrophicans generalisata mitis Hautarzt. 1985;36:176-178.
13. Jonkman MF, De Jong MCJM, Van der Meer JB. Cicatricial junctional epidermolysis bullosa J Am Acad Dermatol 1994;31:286-288.
14. Owaribe K, Nishizawa Y, Franke WW. Isolation and characterization of hemidesmosomes from bovine corneal epithelial cells. Exp Cell Res. 1991;192 622-630.
15. Nishizawa Y, Uematsu J, Owaribe K. HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J Biochem (Tokyo). 1993;113:493-501.
16. Verrando P, Hsi B, Yeh CG, Pisani A, Serieys N, Ortonne J-P. Monoclonal antibody GB3: a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res. 1987;170:116-128.
17. Jonkman MF, De Jong MJCM, Heeres K, Sonnenberg A. Expression of integrin a6β4 in junctional epidermolysis bullosa. J Invest Dermatol. 1992;99:489-496.
18. Bruins S, De Jong MCJM, Heeres K, Wilkinson MHF, Jonkman MF, Van der Meer JB. Fluorescence overlay antigen mapping of the epidermal basement membrane zone, III: topographic staining and effective resolution. J Histochem Cytochem. 1995;43:649-656.
19. Pohla-Gubo G, Lazarova Z, Giudice G, Grassegger A, Hintner H, Yancey K The nicein/epiligrin/kalinin (NEK) complex and related adhesion molecules are present in the epidermal basement membrane of patients with generalized atrophic benign junctional epidermolysis bullosa (GABEB). J Invest Dermatol. 1994; 102:562. Abstract.
20. Fine JD, Horiguchi Y, Couchman JR 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody: definition of a new skin basement membrane antigenic defect in functional and dystrophic epidermolysis bullosa. Arch Dermatol 1989;125:520-523.
21. Verrando P, Schofield OMV, Ishida-Yamamoto A, et al Nicein (BM-600) in junctional epidermolysis bullosa: polyclonal antibodies provide new clues for pathogenic role. J Invest Dermatol 1993;101:738-743.
22. Aberdam D, Galliano M, Vailly J, et al. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the γ2 subunit of nicein/ kalinin (LAMININ-5). Nature Genet. 1994;6 299-304.
23. Pulkkinen L, Christiano AM, Airenne T, Haakana H, Tryggvason K, Uitto J. Mutations in the γ2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nature Genet 1994,6:293-298.
24. Grubauer G, Hintner H, Klein G, Fritsch P. Acquired, surface giant nevus cell nevi in generalized, atrophic, benign epidermolysis bullosa Hautarzt 1989;40:523-526
25. Hacham-Zadeh S. Benign junctional epidermolysis bullosa in threee related Moroccan families. J Am Acad Dermatol. 1986,14:508-509.
26. Hashimoto I, Katabira Y, Mitsuhashi Y, Yasuraoka I, Schnyder UW, Anton-Lamprecht I. Epidermolysis bullosa atrophicans generalisata mitis: report of the first case in Japan. Nippon Hifuka Gakkai Zasshi. 1986;96:623-628
27. Paller AS, Fine JD, Kaplan S, Pearson RW. The generalized atrophic benign form of junctional epidermolysis bullosa. experience with four patients in the United States. Arch Dermatol 1986;122.704-710.
28. Foldes C, Wallach D, Aubiniere E, Vignon-Pennamen MD, Cottenot F Generalized atrophic benign form of junctional epidermolysis bullosa Dermatologica 1988;176:83-90.
29. Prigent F, Blanchet-Bardon C, Mariano A, et al. Non-fatal junctional epidermolysis bullosa (generalized, atrophic and benign) Ann Dermatol Venereol. 1989;116:786-788.
30. Yamada Y, Dekio S, Jidoi J, Ishimoto T, Yoshioka T Epidermolysis bullosa atrophicans generalisata mitis report of a case with renal dysfunction. J Dermatol. 1990;17:690-695.
31. Happle R. Mosaicism in human skin: understanding the patterns and mechanisms. Arch Dermatol 1993;129:1460-1470
32. Ishiko A, Shimizu H, Kikuchi A, Ebihara T, Hashimoto T, Nishikawa T. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin J Clin Invest 1993;91 1608-1615.